Cargando…
Rapid changes in illegally manufactured fentanyl products and prices in the United States
BACKGROUND AND AIMS: Synthetic opioids, mostly illegally manufactured fentanyl (IMF), were mentioned in 60% of United States (US) drug overdose deaths in 2020, with dramatic variation across states that mirrors variation in IMF supply. However, little is known about IMF markets in the United States...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543283/ https://www.ncbi.nlm.nih.gov/pubmed/35543081 http://dx.doi.org/10.1111/add.15942 |
_version_ | 1784804339616841728 |
---|---|
author | Kilmer, Beau Pardo, Bryce Pujol, Toyya A. Caulkins, Jonathan P. |
author_facet | Kilmer, Beau Pardo, Bryce Pujol, Toyya A. Caulkins, Jonathan P. |
author_sort | Kilmer, Beau |
collection | PubMed |
description | BACKGROUND AND AIMS: Synthetic opioids, mostly illegally manufactured fentanyl (IMF), were mentioned in 60% of United States (US) drug overdose deaths in 2020, with dramatic variation across states that mirrors variation in IMF supply. However, little is known about IMF markets in the United States and how they are changing. Researchers have previously used data from undercover cocaine, heroin, and methamphetamine purchases and seizures to examine how their use and related harms respond to changes in price and availability. This analysis used US Drug Enforcement Administration (DEA) data to address two questions: (i) “To what extent does IMF supply vary over time and geography?” and (ii) “What has happened to the purity‐adjusted price of IMF?” METHODS: We developed descriptive statistics and visualizations using data from 66 713 observations mentioning IMF and/or heroin from the DEA's System to Retrieve Information from Drug Evidence (STRIDE; now STARLIMS) from 2013 to 2021. Price regressions were estimated with city‐level fixed effects examining IMF‐only powder observations with purity and price information at the low‐to‐medium wholesale level (>1 g to ≤100 g; n = 964). RESULTS: From 2013 to 2021, the share of heroin and/or IMF observations mentioning IMF grew from near zero to more than two‐thirds. The share of heroin observations also containing IMF grew from <1% to ~40%. There is important geographic variation: in California, most IMF seizures involved counterfeit tablets, whereas New York and Massachusetts largely involved powder formulation. The median price per pure gram of IMF powder sold at the >10 to ≤100 g level fell by more than 50% from 2016 to 2021; regression analyses suggested an average annual decline of 17% (P < 0.001). However, this price decline appears to have been driven by observations from the Northeast. CONCLUSIONS: Since 2013, the illegally manufactured fentanyl problem in the United States has become more deadly and more diverse. |
format | Online Article Text |
id | pubmed-9543283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95432832022-10-14 Rapid changes in illegally manufactured fentanyl products and prices in the United States Kilmer, Beau Pardo, Bryce Pujol, Toyya A. Caulkins, Jonathan P. Addiction Data Insight BACKGROUND AND AIMS: Synthetic opioids, mostly illegally manufactured fentanyl (IMF), were mentioned in 60% of United States (US) drug overdose deaths in 2020, with dramatic variation across states that mirrors variation in IMF supply. However, little is known about IMF markets in the United States and how they are changing. Researchers have previously used data from undercover cocaine, heroin, and methamphetamine purchases and seizures to examine how their use and related harms respond to changes in price and availability. This analysis used US Drug Enforcement Administration (DEA) data to address two questions: (i) “To what extent does IMF supply vary over time and geography?” and (ii) “What has happened to the purity‐adjusted price of IMF?” METHODS: We developed descriptive statistics and visualizations using data from 66 713 observations mentioning IMF and/or heroin from the DEA's System to Retrieve Information from Drug Evidence (STRIDE; now STARLIMS) from 2013 to 2021. Price regressions were estimated with city‐level fixed effects examining IMF‐only powder observations with purity and price information at the low‐to‐medium wholesale level (>1 g to ≤100 g; n = 964). RESULTS: From 2013 to 2021, the share of heroin and/or IMF observations mentioning IMF grew from near zero to more than two‐thirds. The share of heroin observations also containing IMF grew from <1% to ~40%. There is important geographic variation: in California, most IMF seizures involved counterfeit tablets, whereas New York and Massachusetts largely involved powder formulation. The median price per pure gram of IMF powder sold at the >10 to ≤100 g level fell by more than 50% from 2016 to 2021; regression analyses suggested an average annual decline of 17% (P < 0.001). However, this price decline appears to have been driven by observations from the Northeast. CONCLUSIONS: Since 2013, the illegally manufactured fentanyl problem in the United States has become more deadly and more diverse. John Wiley and Sons Inc. 2022-06-08 2022-10 /pmc/articles/PMC9543283/ /pubmed/35543081 http://dx.doi.org/10.1111/add.15942 Text en © 2022 RAND Corporation. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Data Insight Kilmer, Beau Pardo, Bryce Pujol, Toyya A. Caulkins, Jonathan P. Rapid changes in illegally manufactured fentanyl products and prices in the United States |
title | Rapid changes in illegally manufactured fentanyl products and prices in the United States |
title_full | Rapid changes in illegally manufactured fentanyl products and prices in the United States |
title_fullStr | Rapid changes in illegally manufactured fentanyl products and prices in the United States |
title_full_unstemmed | Rapid changes in illegally manufactured fentanyl products and prices in the United States |
title_short | Rapid changes in illegally manufactured fentanyl products and prices in the United States |
title_sort | rapid changes in illegally manufactured fentanyl products and prices in the united states |
topic | Data Insight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543283/ https://www.ncbi.nlm.nih.gov/pubmed/35543081 http://dx.doi.org/10.1111/add.15942 |
work_keys_str_mv | AT kilmerbeau rapidchangesinillegallymanufacturedfentanylproductsandpricesintheunitedstates AT pardobryce rapidchangesinillegallymanufacturedfentanylproductsandpricesintheunitedstates AT pujoltoyyaa rapidchangesinillegallymanufacturedfentanylproductsandpricesintheunitedstates AT caulkinsjonathanp rapidchangesinillegallymanufacturedfentanylproductsandpricesintheunitedstates |